DIA Appoints Co-Chairs for 2016 EuroMeeting in Hamburg
The congress will be held at the Congress Center Hamburg (CCH) in Germany on 6 to 8 April 2016. For the first time, it will feature one or more sessions on medical writing.
Karl Broich, President of the Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) in Germany, and Kemal Malik, a member of the board of management at Bayer AG in Germany, will be the co-chairs of the 28th Drug Information Association (DIA) EuroMeeting.
The congress will be held at the Congress Center Hamburg (CCH) in Germany on 6 to 8 April 2016. For the first time, it will feature one or more sessions on medical writing.
The call for abstracts for presentations, full sessions and tutorials is open until 29 June. Applicants may submit more than one abstract, and they should cover innovation, clinical research, clinical trials, regulatory science, medical affairs, eHealth/big data, pharmacovigilance, lifecycle benefit/risk management, availability of medicinal products, globalization, medical devices and combination products, and health tech assessment.
According to a statement on the DIA web site, the main aim of the 2016 EuroMeeting will be “to provide a platform for experts from all relevant disciplines within the entire healthcare development and access process to debate and find solutions to some of the most pertinent challenges faced in an ever-evolving healthcare system - including the need to drive innovation.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
